Second chances for secondary AML

Blood Adv. 2024 Aug 13;8(15):4221-4222. doi: 10.1182/bloodadvances.2024013318.

Authors

Jacob S Appelbaum^{1

2}, Frederick R Appelbaum^{1

2}, Mary-Elizabeth Percival^{1

2}

Affiliations

¹ Division of Hematology/Oncology, Department of Medicine, University of Washington, Seattle, WA.
² Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.

No abstract available

Publication types

Comment

MeSH terms

Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / therapy
Neoplasms, Second Primary / diagnosis
Neoplasms, Second Primary / etiology